menu
    • menu

    Company profile for TaiMed Biologics

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    TaiMed Biologics was formed on September 4, 2007 to realize the vision of creating a world-class, innovation-based biotechnology company that will satisfy the unmet medical needs of patients around the world. The company will capitalize on its tremendous intellectual, extensive expertise, and management resources to develop a strong health-care product pipeline that benefits patients, rewards investors, and propels ourselves t...
    TaiMed Biologics was formed on September 4, 2007 to realize the vision of creating a world-class, innovation-based biotechnology company that will satisfy the unmet medical needs of patients around the world. The company will capitalize on its tremendous intellectual, extensive expertise, and management resources to develop a strong health-care product pipeline that benefits patients, rewards investors, and propels ourselves to prominence in the biotechnology industry. The company signed an agreement with Genentech for the licensing of Ibalizumab shortly after its formation.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    TaiMed BiologicsTaiwan Flag
    Country
    Country
    Taiwan
    Address
    Address
    3F., No.607, Ruiguang Rd., Neihu Dist., Taipei City 11492
    Telephone
    Telephone
    886-2-26580058
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.taimedbiologics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    TaiMed Biologics and AcedrA BioPharmaceuticals Partner to Commercialize Trogarz
    TaiMed Biologics and AcedrA BioPharmaceuticals Partner to Commercialize Trogarz

    18 Mar 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/03/18/2848020/0/en/TaiMed-Biologics-and-AcedrA-BioPharmaceuticals-Partner-to-Commercialize-Trogarzo-Ibalizumab-uiyk-in-the-Middle-East-and-North-Africa-Region.html

    GLOBENEWSWIRE
    18 Mar 2024
    Share Share
    TaiMed Biologics & AcedrA BioPharmaceuticals Partner to Commercialize Trogarzo
    TaiMed Biologics & AcedrA BioPharmaceuticals Partner to Commercialize Trogarzo

    18 Mar 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/03/18/2848020/0/en/TaiMed-Biologics-and-AcedrA-BioPharmaceuticals-Partner-to-Commercialize-Trogarzo-Ibalizumab-uiyk-in-the-Middle-East-and-North-Africa-Region.html

    GLOBENEWSWIRE
    18 Mar 2024
    Share Share
    TaiMed Announces Significant Progress in Clinical Trials for New HIV Treatment
    TaiMed Announces Significant Progress in Clinical Trials for New HIV Treatment

    16 Oct 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/taimed-announces-significant-progress-in-clinical-trials-for-new-hiv-treatment-301956734.html

    PR NEWSWIRE
    16 Oct 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search